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Summary 
Meta-analyses of diagnostic test accuracy (DTA) studies have been gaining prominence 
in research in clinical epidemiology and health technology development. In these DTA 
meta-analyses, some studies may have markedly different characteristics from the others, 
and potentially be inappropriate to include. The inclusion of these “outlying” studies 
might lead to biases, yielding misleading results. In this article, we develop Bayesian 
methods for detecting outlying studies and their influence diagnostics in DTA meta-
analyses. Synthetic influence measures based on the bivariate hierarchical Bayesian 
random effects models are developed because the overall influences of individual studies 
should be simultaneously assessed by the two outcome variables and their correlation 
information. We propose five synthetic measures for the influence analyses: (1) relative 
distance, (2) standardized residual, (3) Bayesian p-value, (4) posterior distribution of 
scale parameter of scale mixtures of normals, and (5) influence statistic on the area under 
the summary receiver operating characteristic curve. We also show conventional 
univariate Bayesian influential measures can be applied to the bivariate random effects 
models, which can be used as marginal influential measures. We illustrate the 
effectiveness of the proposed methods by applying them to a DTA meta-analysis of 
airway eosinophilia in asthma. 
 
Key words: meta-analysis for diagnostic accuracy studies; bivariate meta-analysis; outlier 
detection; influence diagnostics; summary receiver operating characteristic curve. 
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1. Introduction 
Evidence synthesis methods have been gaining prominence in diagnostic test accuracy 
(DTA) research in clinical epidemiology and health technology development 1,2. Due to 
the methodological developments of DTA meta-analysis, the bivariate meta-analysis 
model is one of the standard methods for these studies, as it enables synthesis of the two 
primary correlated outcomes of diagnostic studies, sensitivity and false positive rate 
(FPR; = 1−specificity), thus borrowing their strengths in statistical inference. In addition, 
the bivariate modeling framework provides a unified formulation that also identifies the 
corresponding summary receiver operating characteristic (SROC) curve 3-7. 
   In DTA meta-analysis, there are systematic heterogeneities between studies in general, 
e.g., study designs, participant characteristics, regions, sites, cut-off of diagnostic markers, 
and outcome definitions. Therefore, the heterogeneity of the diagnostic measure should 
occur commonly, and random effects models are usually adopted 4,8. However, some 
studies might have markedly different characteristics from others, and may exceed the 
degree of statistical heterogeneity that can be adequately explained by the random effects 
model. These “outlying studies” might lead to biases, potentially yielding misleading 
results. These biases might have serious influences on technology assessments and 
policy-making. Therefore, identification and influence diagnostics of the outlying studies 
are relevant to the practice of evidence synthesis research. 
   For outlier detection in DTA meta-analysis, several exploratory methods and 
graphical tools have been discussed in the literature 9-12, but they have limitations due to 
their heuristic and subjective approaches 13. Recently, to address these issues, Negeri and 
Beyene 13 proposed more objective approaches based on the Reitsma’s frequentist 
bivariate random effects model 4. They proposed a bivariate residual-based diagnostic 
method and a test-based method using a mean-shift outlier model within the frequentist 
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framework 13. Besides, Bayesian influence diagnostic methods are another effective 
approaches for these problems 14. In particular, the influence diagnostic methods of Carlin 
and Louis 14 have been widely applied to various statistical problems as useful tools for 
outlier detections. In evidence synthesis methods, Zhang et al. 15 recently developed 
detection and handling methods for trial-level outliers in network meta-analyses using the 
Carlin-Louis-type influence diagnostic methods. However, no such effective methods 
have been established for DTA meta-analyses, although the Bayesian hierarchical 
modeling is another effective approach for these meta-analyses 9,16.  
In this article, we propose Bayesian methods for the identification and influential 
diagnostics of outlying studies in DTA meta-analyses. Especially, we develop synthetic 
influence measures based on the bivariate hierarchical Bayesian random effects models 
because the overall influences of individual studies should be simultaneously assessed by 
the two outcome variables and their correlation information. We propose five methods 
within the Bayesian framework of DTA meta-analyses to detect outlying studies: (1) 
relative distance (RD), (2) standardized residual (SR), (3) Bayesian p-value, and (4) 
posterior distribution of scale parameter of scale mixtures of normals, and (5) influence 
statistic on the area under the SROC curve. We illustrate the effectiveness of the proposed 
methods by applying them to a DTA meta-analysis of airway eosinophilia in asthma 17. 
   The remainder of this paper is organized as follows. In Section 2, we briefly review 
the Bayesian bivariate model for DTA meta-analysis. In Section 3, we present the five 
methods for assessment of outlying studies and influence diagnostics. In Section 4, we 
demonstrate the effectiveness of these methods via application to a DTA meta-analysis 
of airway eosinophilia in asthma 17. Finally, we provide a discussion in Section 5. 
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2. Bayesian bivariate hierarchical random effects model for DTA meta-analysis 
We consider the Bayesian bivariate hierarchical random effects model for sensitivity and 
FPR for meta-analysis of diagnostic test accuracy to address the between-studies 
heterogeneity 9,16. Let 𝑇𝑃௜ , 𝐹𝑃௜ , 𝐹𝑁௜ and 𝑇𝑁௜ be the counts of true positive, false 
positive, false negative, and true negative participants in the 𝑖th study, respectively (𝑖 ൌ
1,2, … , 𝑁). Also, we denote the total numbers of positive and negative diagnoses in the 
𝑖th study as 𝑛஺௜ ൌ 𝑇𝑃௜ ൅ 𝐹𝑁௜, 𝑛஻௜ ൌ 𝐹𝑃௜ ൅ 𝑇𝑁௜. Then, the logit-transformed sensitivity 
and FPR estimators are defined as 𝑌஺௜ ൌ logitሺ𝑇𝑃௜ 𝑛஺௜⁄ ሻ and 𝑌஻௜ ൌ logitሺ𝐹𝑃௜ 𝑛஻௜⁄ ሻ. 
Firstly, we consider the binomial probability model for 𝑇𝑃௜ and 𝐹𝑃௜, 
𝑇𝑃௜~𝐵𝑖𝑛ሺ𝑛஺௜, 𝑝஺௜ሻ, 𝐹𝑃௜~𝐵𝑖𝑛ሺ𝑛஻௜, 𝑝஻௜ሻ. 
where 𝑝஺௜ and 𝑝஻௜ are the sensitivity and FPR for the ith study, respectively. Then, we 
consider the random effects model for the logit-transformed binomial probability 
parameters, 𝜃஺௜ ൌ logitሺ𝑝஺௜ሻ, 𝜃஻௜ ൌ logitሺ𝑝஻௜ሻ, 
𝜽௜~𝑁ሺ𝝁, 𝜮ሻ, 𝜮 ൌ ቆ 𝜎஺
ଶ 𝜌𝜎஺𝜎஻
𝜌𝜎஺𝜎஻ 𝜎஻ଶ ቇ, 
where 𝜽௜ ൌ ሺ𝜃஺௜, 𝜃஻௜ሻ் and 𝝁 ൌ ሺ𝜇஺, 𝜇஻ሻ் , which is the summary logit-transformed 
sensitivity and FPR. 𝜎஺ଶ and 𝜎஻ଶ correspond to the heterogeneity variances of 𝜃஺௜ and 
𝜃஻௜, and 𝜌 is their correlation coefficient. Note that 𝑇𝑃௜ and 𝐹𝑃௜ are assumed to be 
conditional independent given the random effect parameters 𝜃஺௜ and 𝜃஻௜. In Bayesian 
inference, the non-informative prior distributions are usually adopted, e.g., 
𝜇஺, 𝜇஻~𝑁ሺ0, 100ሻ, 𝜎஺, 𝜎஻~𝑈ሺ0.01, 10ሻ, 𝜌~𝑈ሺെ1, 1ሻ. Posterior inferences of the model 
parameters can be implemented using Markov Chain Monte Carlo (MCMC) 18,19. 
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3. Detections of outlying studies and influence diagnostics 
3.1 Relative distance 
To assess whether individual studies have remarkably different characteristics, we 
propose quantifiable measures that are suitable for DTA meta-analyses. The first measure 
is RD, which was proposed by Zhang et al. 15 for network meta-analysis in order to assess 
the influence on the estimate of mean parameter 𝝁 by deleting the 𝑖th study from the 
calculation (i.e. leave-one-out cross-validation). This was proposed as a measure 
resembling Cook’s distance for linear regression analyses 20. The marginal RD for 
sensitivity and FPR of the 𝑖th study are defined by straightforwardly applying the RD 
measure of Zhang et al. 15, 
𝑅𝐷஺௜ ൌ ቤ
?̂?஺ െ ?̂?஺ሺ௜ሻ
?̂?஺ ቤ , 𝑅𝐷஻௜ ൌ ቤ
?̂?஻ െ ?̂?஻ሺ௜ሻ
?̂?஻ ቤ, 
where ?̂?஺ and ?̂?஻ are the estimators of 𝜇஺ and 𝜇஻ obtained from all the data, and 
?̂?஺ሺ௜ሻ and ?̂?஻ሺ௜ሻ are those obtained from the leave-one-out data without the 𝑖th study. 
These estimators are obtained by the Bayesian hierarchical random effects model in 
Section 2 (usually, the posterior means are adopted). Studies with large RD are regarded 
as influential, and then they are judged as outliers in the sense of marginal measures.  
   Besides, in DTA meta-analysis, the primary target to be estimated is substantially the 
grand mean parameter 𝝁 , and it is estimated using both the sensitivity and FPR 
information, as well as their correlation information. Thus, it is more reasonable that the 
influences are assessed as a two-dimensional measure. We then propose a synthetic 
measure for DTA meta-analysis, synthetic relative distance (SRD), which that accounts 
for both sensitivity and FPR,  
𝑆𝑅𝐷௜ ൌ
ට൫?̂?஺ െ ?̂?஺ሺ௜ሻ൯ଶ ൅ ൫?̂?஻ െ ?̂?஻ሺ௜ሻ൯ଶ
ඥ?̂?஺ଶ ൅ ?̂?஻ଶ
. 
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Note that SRD is defined as a relative Euclidean distance in two-dimensional space that 
quantifies the divergence of the obtained estimates from the leave-one-out dataset. 
Another synthetic measure might be the mean of the two marginal measures of 𝑅𝐷஺௜ and 
𝑅𝐷஻௜, 
𝐴𝑅𝐷௜ ൌ 12 ቆቤ
?̂?஺ െ ?̂?஺ሺ௜ሻ
?̂?஺ ቤ ൅ ቤ
?̂?஻ െ ?̂?஻ሺ௜ሻ
?̂?஻ ቤቇ. 
which corresponds to the average RD (ARD) measure of Zhang et al. 15. Geometrically, 
the ARD is solely an averaged relative measure of two one-dimensional Euclidean 
distances. 
   In addition, to assess the influences synthetically, another approach is to evaluate them 
using a synthetic diagnostic measure. A well-used measure is the diagnostic odds ratio 
(DOR) 21, which is defined as a ratio of positive likelihood ratio (𝐿𝑅ሺାሻ) and negative 
likelihood ratio (𝐿𝑅ሺିሻ), 
𝐷𝑂𝑅 ൌ 𝐿𝑅ሺାሻ𝐿𝑅ሺିሻ ൌ
𝑝஺௜ 𝑝஻௜⁄
ሺ1 െ 𝑝஺௜ሻ ሺ1 െ 𝑝஻௜ሻ⁄ . 
The influences on sensitivity and FPR can also be evaluated jointly by the relative 
distance using DOR, 
𝑅𝐷஽ைோ௜ ൌ ቤlog 𝐷𝑂𝑅
෣ െ log 𝐷𝑂𝑅෣ ሺ௜ሻ
log 𝐷𝑂𝑅෣ ቤ.  
Here log 𝐷𝑂𝑅෣  is estimated from the full data by log 𝐷𝑂𝑅෣ ൌ ?̂?஺ െ ?̂?஻ . log 𝐷𝑂𝑅෣ ሺ௜ሻ is 
the estimate obtained from the full data, except for the 𝑖 th study, by log 𝐷𝑂𝑅෣ ሺ௜ሻ ൌ
?̂?஺ሺ௜ሻ െ ?̂?஻ሺ௜ሻ . Note that because DOR is a ratio measure, we transformed them to 
logarithm scale to circumvent having a highly skewed distribution. 
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3.2 Standardized residual 
In another approach based on leave-one-out cross validation, Carlin and Louis 14 and 
Zhang et al. 15 proposed using the SR. The SR is defined as a deviation measure, which 
is the difference in the observed outcome of the ith study and the posterior predictive 
mean obtained from the leave-one-out dataset, standardized by the posterior predictive 
standard deviation. Zhang et al. 15 proposed the SR as a univariate influence diagnostic 
measure for network meta-analysis, and it can be applied to DTA analyses 
straightforwardly, 
𝑆𝑅஺௜ ൌ
𝑦஺௜ െ 𝐸ሺ𝑌஺௜|𝒚ሺ௜ሻሻ
ඥ𝑉𝑎𝑟ሺ𝑌஺௜|𝒚ሺ௜ሻሻ
, 𝑆𝑅஻௜ ൌ
𝑦஻௜ െ 𝐸ሺ𝑌஻௜|𝒚ሺ௜ሻሻ
ඥ𝑉𝑎𝑟ሺ𝑌஻௜|𝒚ሺ௜ሻሻ
, 
where 𝐸ሺ𝑌஺௜|𝒚ሺ௜ሻሻ  and 𝐸ሺ𝑌஻௜|𝒚ሺ௜ሻሻ  are the posterior predictive means, and 
𝑉𝑎𝑟ሺ𝑌஺௜|𝒚ሺ௜ሻሻ and 𝑉𝑎𝑟ሺ𝑌஻௜|𝒚ሺ௜ሻሻ are the posterior predictive variances obtained from 
the leave-one-out dataset without the 𝑖th study. In addition, these measures only reflect 
marginal information. Similar to RD, we propose a synthetic measure called the synthetic 
standardized residual (SSR), 
𝑆𝑆𝑅௜ ൌ ቀ𝒚௜ െ 𝐸൫𝒀௜ห𝒚ሺ௜ሻ൯ቁ
் 𝑉൫𝒀௜ห𝒚ሺ௜ሻ൯ିଵ ቀ𝒚௜ െ 𝐸൫𝒀௜ห𝒚ሺ௜ሻ൯ቁ 
where 𝒚௜ ൌ ሺ𝑦஺௜, 𝑦஻௜ሻ் , 𝐸൫𝒀௜ห𝒚ሺ௜ሻ൯ ൌ ൫𝐸ሺ𝑌஺௜|𝒚ሺ௜ሻሻ, 𝐸ሺ𝑌஻௜|𝒚ሺ௜ሻሻ൯் . Also, 𝑉൫𝒀௜ห𝒚ሺ௜ሻ൯ is 
the posterior predictive covariance matrix obtained from the leave-one-out dataset lacking 
the ith study. In calculations of 𝐸൫𝒀௜ห𝒚ሺ௜ሻ൯ and 𝑉൫𝒀௜ห𝒚ሺ௜ሻ൯, the following conditional 
predictive distribution is used, 
𝑓൫𝒚௜ห𝒚ሺ௜ሻ൯ ൌ 𝑓ሺ𝒚௜ሻ𝑓ሺ𝒚ሺ௜ሻሻ ൌ න 𝑓ሺ𝒚௜|𝜽, 𝒚ሺ௜ሻሻ𝑝ሺ𝜽|𝒚ሺ௜ሻሻ 𝑑𝜽. 
Here, 𝜽 indicates an entire parameter vector, 𝜽 ൌ ሺ𝝁், 𝜎஺ଶ, 𝜎஻ଶ, 𝜌ሻ். Note that the SSR is 
defined as the standardized deviation in two-dimensional space that quantifies the 
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divergence of the observed statistics of the ith study from those of the leave-one-out 
dataset. In addition, the average SR (ASR), which was proposed by Zhang et al. 15, can 
also be applied to the DTA analyses as another synthetic measure, 
𝐴𝑆𝑅௜ ൌ 12 ቆቤ
𝑦஺௜ െ 𝐸ሺ𝑌஺௜|𝒚ሺ௜ሻሻ
ඥ𝑉𝑎𝑟ሺ𝑌஺௜|𝒚ሺ௜ሻሻ
ቤ ൅ ቤ𝑦஻௜ െ 𝐸ሺ𝑌஻௜|𝒚ሺ௜ሻሻඥ𝑉𝑎𝑟ሺ𝑌஻௜|𝒚ሺ௜ሻሻ
ቤቇ. 
   Also, we can discuss the standardized measure of DOR as a synthetic diagnostic 
measure, 
𝑆𝑅஽ைோ௜ ൌ
log 𝐷𝑂𝑅ప෣ െ 𝐸ሺlog 𝐷𝑂𝑅௜ |𝒚ሺ௜ሻሻ
ඥ𝑉𝑎𝑟ሺlog 𝐷𝑂𝑅௜ |𝒚ሺ௜ሻሻ
. 
Here, log 𝐷𝑂𝑅ప෣  is observed log-transformed diagnostic odds ratio for the 𝑖th study, and 
𝐸ሺlog 𝐷𝑂𝑅௜ |𝒚ሺ௜ሻሻ  and 𝑉𝑎𝑟ሺlog 𝐷𝑂𝑅௜ |𝒚ሺ௜ሻሻ  are the posterior predictive mean and 
variance obtained from the leave-one-out dataset, respectively. Because DOR is defined 
as an odds ratio of 𝑝஺௜  and 𝑝஻௜ , the posterior predictive distribution can be 
straightforwardly constructed in the MCMC. 
 
3.3 Bayesian p-value 
The Bayesian p-value is a well-established measure for posterior predictive model 
checking 14,22, which evaluates the discrepancy between the observed data and the 
posterior predictive samples obtained from the hierarchical Bayesian model by p-value. 
To introduce the Bayesian p-value, we define the following discrepancy measures for 
sensitivity and FPR, respectively 14,22, 
𝐷௜஺ሺ𝑦஺௜, 𝜽ሻ ൌ
ሾ𝑦஺௜ െ 𝐸ሺ𝑌஺௜|𝜽ሻሿଶ
𝑉𝑎𝑟ሺ𝑌஺௜|𝜽ሻ , 𝐷௜
஻ሺ𝑦஻௜, 𝜽ሻ ൌ
ሾ𝑦஻௜ െ 𝐸ሺ𝑌஻௜|𝜽ሻሿଶ
𝑉𝑎𝑟ሺ𝑌஻௜|𝜽ሻ  
where 𝐸ሺ𝑌஺௜|𝜽ሻ and 𝐸ሺ𝑌஻௜|𝜽ሻ are the posterior predictive means, and 𝑉𝑎𝑟ሺ𝑌஺௜|𝜽ሻ and 
𝑉𝑎𝑟ሺ𝑌஻௜|𝜽ሻ are the posterior predictive variances. Then, we consider similar discrepancy 
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measures defined by hypothetical future observations 𝑦஺௜∗   and 𝑦஻௜∗  , 𝐷௜஺ሺ𝑦஺௜∗ , 𝜽ሻ  and 
𝐷௜஻ሺ𝑦஻௜∗ , 𝜽ሻ, where 𝑦஺௜∗  and 𝑦஻௜∗  are posterior predictive samples generated by MCMC. 
The Bayesian p-values are defined as measures of extremeness of observed data from 
these measures, defined for sensitivity and FPR, respectively. 
𝑃஽೔ಲ ൌ 𝑃ሾ𝐷௜஺ሺ𝑦஺௜∗ , 𝜽ሻ ൐ 𝐷௜஺ሺ𝑦஺௜, 𝜽ሻ|𝒚ሿ ൌ න 𝑃ሾ𝐷௜஺ሺ𝑦஺௜∗ , 𝜽ሻ ൐ 𝐷௜஺ሺ𝑦஺௜, 𝜽ሻ|𝜽ሿ𝑝ሺ𝜽|𝒚ሻ 𝑑𝜽, 
𝑃஽೔ಳ ൌ 𝑃ሾ𝐷௜஻ሺ𝑦஻௜∗ , 𝜽ሻ ൐ 𝐷௜஻ሺ𝑦஻௜, 𝜽ሻ|𝒚ሿ ൌ න 𝑃ሾ𝐷௜஻ሺ𝑦஻௜∗ , 𝜽ሻ ൐ 𝐷௜஻ሺ𝑦஻௜, 𝜽ሻ|𝜽ሿ𝑝ሺ𝜽|𝒚ሻ 𝑑𝜽. 
If the p-values 𝑃஽೔ಲ or 𝑃஽೔ಳ are substantially small, it indicates that the observed data 
are extreme compared to the posterior predictive distribution. Then, the corresponding 
study is considered to be an outlying study, and possibly an influential one.  
Although the previous two p-values are marginal diagnostic measures, we can also 
discuss another Bayesian p-value using the synthetic discrepancy measure defined in the 
previous sections. We use the two-dimensional discrepancy measure to define the 
diagnostic measure, 
𝑆𝐷௜ሺ𝒚௜, 𝜽ሻ ൌ ൫𝒚௜ െ 𝐸ሺ𝒀௜|𝜽ሻ൯்𝑉ሺ𝒀௜|𝜽ሻିଵ൫𝒚௜ െ 𝐸ሺ𝒀௜|𝜽ሻ൯, 
and we propose the Bayesian p-value using the two-dimensional information, 
𝑃ௌ஽೔ ൌ 𝑃ሾ𝑆𝐷௜ሺ𝒚௜∗, 𝜽ሻ ൐ 𝑆𝐷௜ሺ𝒚௜, 𝜽ሻ|𝒚ሿ ൌ න 𝑃ሾ𝑆𝐷௜ሺ𝒚௜∗, 𝜽ሻ ൐ 𝑆𝐷௜ሺ𝒚௜, 𝜽ሻ|𝜽ሿ𝑝ሺ𝜽|𝒚ሻ 𝑑𝜽. 
The Bayesian p-value reflects the discrepancy information in two-dimensional space, and 
would be suitable for assessing the influences in DTA meta-analyses. Also, we can simply 
define the Bayesian p-value for averaged marginal discrepancy measures according to 
Zhang et al. 15, 
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𝐴𝐷௜ሺ𝒚௜, 𝜽ሻ ൌ ሾ𝑦஺௜ െ 𝐸ሺ𝑌஺௜|𝜽ሻሿ
ଶ
𝑉𝑎𝑟ሺ𝑌஺௜|𝜽ሻ ൅
ሾ𝑦஻௜ െ 𝐸ሺ𝑌஻௜|𝜽ሻሿଶ
𝑉𝑎𝑟ሺ𝑌஻௜|𝜽ሻ , 
𝑃஺஽೔ ൌ 𝑃ሾ𝐴𝐷௜ሺ𝒚௜∗, 𝜽ሻ ൐ 𝐴𝐷௜ሺ𝒚௜, 𝜽ሻ|𝒚ሿ ൌ න 𝑃ሾ𝐴𝐷௜ሺ𝒚௜∗, 𝜽ሻ ൐ 𝐴𝐷௜ሺ𝒚௜, 𝜽ሻ|𝜽ሿ𝑝ሺ𝜽|𝒚ሻ 𝑑𝜽. 
Also, we can define the Bayesian p-value for DOR, 
𝑃஽ವೀೃ೔ ൌ 𝑃ൣ𝐷൫log 𝐷𝑂𝑅ప∗෣ , 𝜽൯ ൐ 𝐷൫log 𝐷𝑂𝑅ప෣ , 𝜽൯|𝒚൧. 
where 
𝐷஽ைோ௜൫log 𝐷𝑂𝑅ప෣ , 𝜽൯ ൌ ൣlog 𝐷𝑂𝑅ప
෣ െ 𝐸ሺlog 𝐷𝑂𝑅௜ |𝜽ሻ൧ଶ
𝑉𝑎𝑟ሺlog 𝐷𝑂𝑅௜ |𝜽ሻ . 
Here, log 𝐷𝑂𝑅ప෣  is the observed log-transformed diagnostic odds ratio for the 𝑖th study, 
and log 𝐷𝑂𝑅ప∗෣  is hypothetical future data from a posterior predictive sample for the 𝑖th 
study. The posterior mean and variance for log-transformed DOR for the 𝑖th study are 
also obtained from MCMC.  
 
3.4 Posterior estimate of scale parameter of scale mixtures of normals 
In another approach to assessing the outliers, we consider the posterior estimate of scale 
parameter of scale mixtures of normals. The scale mixture of normals was originally 
proposed by Andrews and Mallows 23, and then Carlin and Louis 14 proposed to use them 
to detect outliers in Bayesian models. By using the scale mixtures of normals, we can 
extend normally distributed errors to heavily tailed errors (e.g. Student’s t errors). 
   We consider applying Carlin and Louis 14’s approach to the DTA meta-analysis. To 
adapt their method, we consider another hierarchical Bayesian model based on the 
asymptotic normal approximation of the logit-transformed estimators of sensitivity and 
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FPR, which is another well-established model for DTA meta-analysis developed by 
Reitsma et al. 4. First, we consider the following model, which adopts the scale mixture 
of normal instead of the ordinary normal error model, 
൬𝑌஺௜𝑌஻௜൰ ~𝑁 ൭൬
𝜃஺௜
𝜃஻௜൰ , ቆ
𝜆஺௜𝜔஺௜ଶ 0
0 𝜆஻௜𝜔஻௜ଶ ቇ൱ 
where 𝑌஺௜ and 𝑌஻௜ are logit-transformed estimators of sensitivity and FPR, 𝜃஺௜ and 
𝜃஻௜ are their mean parameters, 𝜆஺௜ and 𝜆஻௜ are scale parameters, and 𝜔஺௜ଶ  and 𝜔஻௜ଶ  
are within-study variance parameters for the 𝑖th study. Second, we consider the random 
effects model, 
൬𝜃஺௜𝜃஻௜൰ ~𝑁 ൭ቀ
𝜇஺𝜇஻ቁ , ቆ
𝜎஺ଶ 𝜌𝜎஺𝜎஻
𝜌𝜎஺𝜎஻ 𝜎஻ଶ ቇ൱. 
Here, 𝜇஺  and 𝜇஻  are the overall mean parameters and 𝜎஺，𝜎஻ , and 𝜌  are the 
heterogeneity variances and correlation coefficient. Assuming adequate prior 
distributions to these parameters, we can obtain posterior estimates of them using MCMC. 
Note that using the scale mixture of normals, we can assess the adequacy of the 
assumption of normal errors, i.e., when 𝜆஺௜ or 𝜆஻௜ equals 1, the assumed distribution 
accords to the ordinary normal distribution, but if not, it would be non-normal heavily 
tailed distributions. Thus, if a study has posterior distributions of scale parameter 𝜆஺௜ or 
𝜆஻௜ greater than 1 with large probability, the study may be considered to have non-normal 
error, and therefore might be considered to be an outlying study. For the prior distributions 
of 𝜆஺௜ and 𝜆஻௜, two types of distribution are widely used; inverse gamma distribution 
𝜆஺௜, 𝜆஻௜~𝐼𝐺ሺ𝜐 2⁄ , 2 𝜐⁄ ሻ  and exponential distribution  𝜆஺௜, 𝜆஻௜~𝐸𝑋𝑃ሺ2ሻ.  The two 
choices correspond to useful parametric error models; the former is the Student’s t error 
with 𝜐 degrees of freedom, and the latter is the double exponential error. 
   In addition to the methods described above, another approach would be to assume 
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equality of the two scale parameters, 𝜆௜ ൌ 𝜆஺௜ ൌ 𝜆஻௜, in the Bayesian model, and then 
conduct the posterior inference of the common scale parameter (CSP) 𝜆௜; we refer to this 
as the CSP model. Using this model, the resultant posterior estimate of 𝜆௜ reflects the 
joint information of the discrepancy of the corresponding ith study; thus, we can assess 
the potential outlying study via a single parameter. 
 
3.5 Influence on the area under the summary receiver operating characteristic curve 
In DTA meta-analyses, the AUC of the SROC curve is widely used to assess overall 
diagnostic ability. Influence analyses can be straightforwardly adapted to the AUC by 
deleting a study from the full data. Because the AUC can be directly interpreted as a 
summary measure of diagnostic performance, it would be useful to assess how influential 
each individual study is. After the posterior estimates of bivariate hierarchical random 
effects model in Section 2 are obtained, the SROC curve and AUC are estimated as 
follows 4. 
1. Estimate the regression line of logit-transformed FPR on logit-transformed sensitivity, 
𝐸ሾ𝑌஺|𝑌஻ሿ ൌ ?̂?஺ ൅ 𝜌ො𝜎ො஺𝜎ො஻𝜎ො஻ଶ ሺ𝑌஻ െ ?̂?஻ሻ. 
2. Transform the regression line from logit scale back to the original (0–1) scale. 
3. Estimate the AUC using the SROC curve by the ordinary method 2,5. 
   Then, influences of individual studies are evaluated using the following measure, 
𝛥𝐴𝑈𝐶௜ ൌ 𝐴𝑈𝐶෣ െ 𝐴𝑈𝐶෣ሺ௜ሻ 
where 𝐴𝑈𝐶෣  is estimated from the full data and 𝐴𝑈𝐶෣ሺ௜ሻ is the corresponding value after 
deletion of the 𝑖th study. A study with a large value of the 𝛥𝐴𝑈𝐶௜ would be considered 
as an outlying study. 
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4. Applications: DTA meta-analysis of airway eosinophilia in asthma 
To illustrate the proposed methods, we analyzed a dataset from a DTA meta-analysis of 
airway eosinophilia in asthma of Korevaar et al. 17. Although eosinophilic airway 
inflammation is associated with elevated corticosteroid responsiveness in asthma, direct 
airway sampling methods are invasive or laborious. Thus, minimally invasive markers 
for diagnosis have been investigated. Korevaar et al. 17 conducted meta-analyses of 
several minimally invasive diagnostic markers using DTA meta-analysis methods. Here, 
we applied our methods to their meta-analysis, especially, to their meta-analysis of the 
fraction of exhaled nitric oxide (FeNO), which involved 12 diagnostic studies. The data 
from these 12 studies are presented in Table 1. In computations of these analyses, we used 
OpenBUGS version 3.2.3 18,19 and R version 3.5.1 24. We conducted 120,000 iterations 
and discarded the first 20,000 iterations as the burn-in period for MCMC. 
In Figure 1, we present the results for RD and SR. The vertical axis corresponds to 
the estimated values of RD or SR, and the horizontal axis corresponds to the study ID that 
was deleted from the dataset. The 10 panels correspond to (a) RD for sensitivity, (b) RD 
for FPR, (c) SRD, (d) ARD, (e) RD for DOR, (f) SR for sensitivity, (g) SR for FPR, (h) 
SSR, (i) ASR, and (j) SR for DOR. For the synthetic RD, only studies 3 and 10 had SRD 
greater than 0.1, the threshold value used by Zhang et al. 15; therefore, they would be 
considered as possible outlying studies. Because study 3 had the lowest FPR and study 
10 the lowest sensitivity, they might be influential for estimating the mean parameter 𝝁. 
For the SSR, only study 1 had an SSR larger than 4.61, which is in the upper 10th 
percentile of the chi-square distribution with two degrees of freedom. Thus, we 
considered that study 1, which has the highest FPR, might be an outlying study. Studies 
3 and 10 had also relatively large SSRs, but their values were smaller than the threshold. 
In regard to DOR, studies 3 and 8 had larger RD than other studies, and study 3 had the 
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largest SR in absolute scale; therefore they were considered as outlying studies and may 
have been influential on the DOR.  
In Table 2, we show the Bayesian p-values for sensitivity, FPR, synthetic discrepancy 
measure, average discrepancy measure, and DOR. Study 3 had the smallest p-values, < 
0.10, for FPR, synthetic discrepancy measure, average discrepancy measure, and DOR; 
some of these values were less than 0.05. Thus, study 3 was identified as a potentially 
outlying study based on the Bayesian p-values.  
In Table 3, we present the results of posterior estimate of scale parameter of scale 
mixtures of normals. In the table, we show that the posterior probabilities of the scale 
parameter were greater than 1 for sensitivity, FPR, and CSP. We used inverse gamma 
IG(1, 1) and exponential EXP(2) as prior distributions for 𝜆௜. For heuristic evaluations, 
using 0.7 as the threshold value, studies 1, 3, and 5 had Prሺ𝜆௜ ൐ 1ሻ ൐ 0.7 for CSP, 
indicating that these studies should be considered as possible outlying studies. Studies 1 
and 3 had the largest and smallest FPR, respectively, and study 5 had high sensitivity and 
a large number of subjects. The selection of prior distributions for 𝜆௜ had little impact 
on the results of our application. 
In Figure 2, we present the results of influence analyses on AUC by deleting each 
study individually. Although 𝛥𝐴𝑈𝐶௜ was smaller than 0.01 for most of the 12 studies, 
the values for studies 5, 6, and 8 were 0.031, 0.016 and -0.016, respectively. These three 
studies had relatively large 𝛥𝐴𝑈𝐶௜ values, suggesting that they are influential studies. 
Studies 5 and 6 had high sensitivity, and studies 5 and 8 had large numbers of subject; 
consequently, these studies had large influences on the AUC. 
Finally, we compared the results of a DTA meta-analysis involving all 12 studies with 
those of a meta-analysis lacking the potentially outlying studies. In Table 4, we present 
the summaries of the potentially outlying studies, identified by the preceding analyses. 
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Study 3 was identified as potentially outlying by four methods, and studies 1, 5, and 8 
were identified by two methods. On the other hand, studies 2, 4, 7, 9, 11, and 12 were not 
judged as outlying by any method. After deleting these potentially outlying studies, the 
pooled sensitivity estimates ranged between 0.62 and 0.69, the pooled FPR estimates 
between 0.19 and 0.29, the areas under SROC curve between 0.701 and 0.760, and the 
pooled DOR estimates between 5.54 and 7.16. In Figure 3, we present plots of the SROC 
curves for these analyses. Most of the SROC curves did not differ significantly from the 
original result obtained using all 12 studies (the upper left panel). However, the SROC 
curve without the outlying studies, identified by the influences on the AUC (the bottom 
right panel), was explicitly changed because the exclusion criterion was determined by 
𝛥𝐴𝑈𝐶௜ . However, through detailed evaluations by our proposed methods, significant 
influences that changed the conclusions of this meta-analysis would not be detected. The 
conclusions of the original analysis are supported by these various influence analyses. 
 
5. Discussion 
In this paper, we proposed Bayesian methods for detecting outlying studies and influence 
diagnosis for DTA meta-analyses. Similar methods have been already discussed for 
network meta-analysis 15, but the marked characteristic of DTA meta-analysis is that the 
outcomes are evaluated by bivariate joint models, and the primary outputs are special 
diagnostic measures, e.g., DOR, the SROC curve, and its AUC 25. Thus, special methods 
that are suitable for these assessments are needed for more appropriate scientific 
evaluations of diagnostic tools or markers.  
In our methods, we need to specify some threshold values for identifying potential 
outlying studies explicitly. This might make it difficult to apply these methods in practice, 
but this is a common and general problem in outlier detections and influence diagnostics 
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26,15. Adequacy depends on the case-by-case situation, and strict guidelines would be 
difficult to set up. However, several characteristics of these methods would be useful for 
these evaluations. First, if sensitivity or FPR is near 0.5, the denominator of RD ?̂?஺ or 
?̂?஻ has a value near zero, and RD tends to have large value. On the other hand, if ?̂?஺ or 
?̂?஻ has a relatively large absolute value, RD tends to be small even if there is a meaningful 
impact of deleting a study. Second, if the number of studies in a meta-analysis is small, 
the weight of each study becomes large, and the detection methods based on leave-one-
out cross validation (i.e. RD, SR and influence on the AUC) tend to generate relatively 
large values. In addition, we should be careful about the multiplicity of these analyses. 
Because we must conduct a large number of analyses for these evaluations, extreme 
results may be observed by chance. This is also a common problem in influence 
diagnostics, and should be taken into account in practical situations.  
   We illustrated the effectiveness of the proposed methods by applying them to a DTA 
meta-analysis for airway eosinophilia in asthma in Section 4. Our methods enabled us to 
identify potential outlying studies and quantitatively evaluate their influence the overall 
results. Although any significant numerical evidence that there were some influential 
studies possibly to change the overall conclusions was not found, various quantitative 
evidence certainly supports the robustness of the main conclusions of that study. Such 
quantitative evidence would also be useful for policy-making and health technology 
assessments that use integrated evidence from these meta-analyses. 
 
Data Availability Statement 
The DTA meta-analysis dataset used in Section 4 is involved in published data in 
Korevaar et al. 17. 
 
16 
 
 
Acknowledgements 
This study was supported by Grants-in-Aid for Scientific Research from the Japan Society 
for the Promotion of Science (Grant numbers: JP19H04074, JP17K19808). 
 
References 
1. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of 
diagnostic and screening tests. BMJ. 2001;323(7305):157-162. 
2. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM, Cochrane Diagnostic Test 
Accuracy Working G. Systematic reviews of diagnostic test accuracy. Ann Intern 
Med. 2008;149(12):889-897. 
3. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models 
for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007;8(2):239-251. 
4. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. 
Bivariate analysis of sensitivity and specificity produces informative summary 
measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982-990. 
5. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of 
diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865-2884. 
6. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: 
multivariate approach and meta-regression. Stat Med. 2002;21(4):589-624. 
7. van Houwelingen HC, Zwinderman KH, Stijnen T. A bivariate approach to meta-
analysis. Stat Med. 1993;12(24):2273-2284. 
8. Arends LR, Hamza TH, van Houwelingen JC, Heijenbrok-Kal MH, Hunink MG, 
Stijnen T. Bivariate random effects meta-analysis of ROC curves. Med Decis 
Making. 2008;28(5):621-638. 
9. Verde PE. Meta-analysis of diagnostic test data: a bivariate Bayesian modeling 
17 
 
 
approach. Stat Med. 2010;29(30):3088-3102. 
10. Verde PE. bamdit: an R package for Bayesian meta-analysis of diagnostic test data. 
J Stat Softw. 2018;86(10). 
11. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy 
studies [computer program]. Statistical Software Components S456880, Boston 
College Department of Economics; 2007. 
12. Harbord RM, Whiting P. metandi: Meta-analysis of diagnostic accuracy using 
hierarchical logistic regression. Stata J. 2009;9(2):211-229. 
13. Negeri ZF, Beyene J. Statistical methods for detecting outlying and influential 
studies in meta-analysis of diagnostic test accuracy studies. Stat Methods Med Res.  
DOI: 10.1177/0962280219852747. 
14. Carlin BP, Louis TA. Bayesian Methods for Data Analysis. 3rd ed. Boca Raton, 
FL: Chapman and Hall/CRC Press; 2009. 
15. Zhang J, Fu H, Carlin BP. Detecting outlying trials in network meta-analysis. Stat 
Med. 2015;34(19):2695-2707. 
16. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse 
data: a generalized linear mixed model approach. J Clin Epidemiol. 
2006;59(12):1331-1333. 
17. Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally 
invasive markers for detection of airway eosinophilia in asthma: a systematic 
review and meta-analysis. Lancet Respir Med. 2015;3(4):290-300. 
18. Lunn D, Jackson C, Best N, Thomas A, Spiegelhalter D. The BUGS Book: A 
Practical Introduction to Bayesian Analysis. Boca Raton: Chapman and 
Hall/CRC; 2012. 
19. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, 
18 
 
 
critique and future directions. Stat Med. 2009;28(25):3049-3067. 
20. Belsley DA, Kuh E, Welsch RE. Regression Diagnostics : Identifying Influential 
Data and Sources of Collinearity. Hoboken, New Jersey: John Wiley & Sons; 
1980. 
21. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds 
ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129-
1135. 
22. Gelman A, Carlin JB, Stern HS, Dunson DB, Vehtari A, Rubin DB. Bayesian Data 
Analysis. 3rd ed. Boca Raton, FL: Chapman and Hall/CRC Press; 2013. 
23. Andrews DF, Mallows CL. Scale mixtures of normal distributions. J Royal Stat 
Soc B. 1974;36(1):99-102. 
24. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, 
Austria: R Foundation for Statistical Computing; 2018. 
25. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: 
Analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, eds. 
Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 
1.0. The Cochrane Collaboration; 2010. 
26. Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. 
Res Synth Methods. 2010;1(2):112-125. 
 
 
 
Table 1. Results from 12 diagnostic accuracy studies for airway eosinophilia in asthma†. 
 
ID Study TP FP FN TN Sensitivity FPR 
       [95% CI] [95% CI] 
1  Lemiere et al (2006) 17 24 4 15 0.81 [0.58, 0.95] 0.62 [0.45, 0.77] 
2  ten Brinke et al (2001) 19 11 6 28 0.76 [0.55, 0.91] 0.28 [0.15, 0.45] 
3  Hillas et al (2011) 10 1 4 25 0.71 [0.42, 0.92] 0.04 [0.00, 0.20] 
4  Meijer et al (2002) 43 8 36 29 0.54 [0.43, 0.66] 0.22 [0.10, 0.38] 
5  Westerhof et al (2014) 92 66 21 147 0.81 [0.73, 0.88] 0.31 [0.25, 0.38] 
6  Yap et al (2013) 18 14 3 19 0.86 [0.64, 0.97] 0.42 [0.25, 0.61] 
7  De Carvalho-Pinto et al (2012) 34 2 19 12 0.64 [0.50, 0.77] 0.14 [0.02, 0.43] 
8  Hastie et al (2013) 49 58 27 104 0.64 [0.53, 0.75] 0.36 [0.28, 0.44] 
9  Tseliou et al (2010) 23 1 22 10 0.51 [0.36, 0.66] 0.09 [0.00, 0.41] 
10  Jia et al (2012) 17 1 26 12 0.40 [0.25, 0.56] 0.08 [0.00, 0.36] 
11  Greulich et al (2012) 48 14 29 44 0.62 [0.51, 0.73] 0.24 [0.14, 0.37] 
12  Schleich et al (2013) 147 59 78 224 0.65 [0.59, 0.72] 0.21 [0.16, 0.26] 
 
† TP: true positive, FP: false positive, FN: false negative, TN: true negative, FPR: false positive rate, CI: confidence interval. 
 
  
 
 
 
Table 2. Bayesian p-values.  
 
ID Study Sensitivity FPR Synthetic Average DOR 
              
1  Lemiere et al (2006) 0.9843  0.4683  0.7570  0.7578  0.6373  
2  ten Brinke et al (2001) 0.5432  0.9923  0.8159  0.8216  0.6030  
3  Hillas et al (2011) 0.2565  0.0488  0.0493  0.0864  0.0176  
4  Meijer et al (2002) 0.6068  0.7038  0.7831  0.8114  0.5204  
5  Westerhof et al (2014) 0.4228  0.8855  0.7166  0.7182  0.4512  
6  Yap et al (2013) 0.2278  0.8214  0.4826  0.4686  0.3633  
7  De Carvalho-Pinto et al (2012) 0.9375  0.5618  0.8154  0.8348  0.5204  
8  Hastie et al (2013) 0.5769  0.7184  0.7932  0.8028  0.4986  
9  Tseliou et al (2010) 0.6945  0.5062  0.7791  0.7276  0.6015  
10  Jia et al (2012) 0.4467  0.6836  0.7164  0.6707  0.9619  
11  Greulich et al (2012) 0.7975  0.8560  0.9395  0.9483  0.7345  
12  Schleich et al (2013) 0.9710  0.9617  0.9981  0.9982  0.9546  
 
 
  
 
 
 
Table 3. Posterior estimates of the scale parameter of scale mixtures of normals (probabilities of posterior scale 
parameter are greater than 1) †. 
 
ID Study Sensitivity FPR CSP 
     IG EXP IG EXP IG EXP 
1  Lemiere et al (2006) 0.58  0.55  0.81  0.77  0.74  0.73  
2  ten Brinke et al (2001) 0.57  0.57  0.55  0.53  0.52  0.51  
3  Hillas et al (2011) 0.54  0.54  0.83  0.85  0.78  0.82  
4  Meijer et al (2002) 0.63  0.62  0.54  0.54  0.56  0.55  
5  Westerhof et al (2014) 0.74  0.72  0.61  0.58  0.73  0.72  
6  Yap et al (2013) 0.66  0.66  0.62  0.60  0.65  0.66  
7  De Carvalho-Pinto et al (2012) 0.55  0.54  0.57  0.57  0.50  0.51  
8  Hastie et al (2013) 0.59  0.58  0.66  0.63  0.61  0.61  
9  Tseliou et al (2010) 0.63  0.60  0.58  0.58  0.57  0.58  
10  Jia et al (2012) 0.74  0.71  0.60  0.59  0.70  0.69  
11  Greulich et al (2012) 0.57  0.56  0.55  0.55  0.50  0.49  
12  Schleich et al (2013) 0.59  0.58  0.64  0.61  0.59  0.59  
 
†FPR: false positive rate, IG: inverse gamma distribution for prior distribution of scale parameter, EXP: exponential 
distribution for prior distribution of scale parameter, CSP: common scale parameter (calculated by the CSP model). 
 
  
 
 
 
Table 4. Comparison of pooled sensitivity and false positive rate, area under the SROC curve, and diagnostic odds ratio between results of meta-analysis from all 12 
diagnostic accuracy studies and results obtained after deleting potential outlying studies †. 
 
  Outlying study Sensitivity  FPR  AUC  DOR 
    [95% CI]  [95% CI]  [95% CI]  [95% CI] 
All studies - 0.66 [0.56, 0.76]  0.24 [0.13, 0.35]  0.743 [0.648, 0.806]  6.47 [3.95, 11.37] 
Without outlying studies identified by          
Relative distance Study 3, 10 0.69 [0.60, 0.78]  0.29 [0.18, 0.40]  0.740 [0.643, 0.802]  5.63 [3.46, 9.26] 
Standardized residual Study 1 0.65 [0.55, 0.75]  0.22 [0.13, 0.31]  0.741 [0.596, 0.813]  6.64 [4.07, 11.63] 
Bayesian p-value Study 3 0.67 [0.56, 0.77]  0.26 [0.16, 0.37]  0.743 [0.649, 0.801]  5.73 [3.57, 9.34] 
Posterior estimate of scale parameter 
of scale mixture of normals Study 1, 3, 5 0.62 [0.52, 0.72]  0.23 [0.14, 0.33]  0.711 [0.548, 0.794]  5.54 [3.34, 9.60] 
Diagnostic odds ratio Study 3, 8 0.67 [0.54, 0.79]  0.25 [0.14, 0.37]  0.760 [0.665, 0.816]  6.39 [3.79, 10.65] 
Influence analysis on the AUC Study 5, 6, 8 0.62 [0.51, 0.72]  0.19 [0.08, 0.35]  0.701 [0.570, 0.798]  7.16 [3.39, 16.81] 
 
† SROC: summary receiver operating characteristic, FPR: false positive rate, CI: confidence interval, AUC: area under the summary receiver operating characteristic curve, 
DOR: diagnostic odds ratio. 
‡ Thresholds for identifying outlying studies are 0.1 for relative distance, 4.61 (upper 10 percentile of χଶଶ distribution) for standardized residual, 0.10 for Bayesian p-value, 
Prሺ𝜆௜ ൐ 1ሻ ൐ 0.70 for posterior estimate of scale parameter of scale mixture of normals, and 0.015 for influence analysis on the AUC. 
  
 
 
 
 
 
 
Figure 1. Relative distances and standardized residuals by leave-one-out influence analyses (RD: relative distance, SRD: synthetic relative distance, ARD: average relative 
distance, DOR: diagnostic odds ratio, SR: standardized residual, SSR: synthetic standardized residual, ASR: average standardized residual). 
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Figure 2. Results of influence analyses on the AUC. 
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Figure 3. Scatter plot of sensitivity and false positive rate with and without potential outlying studies (white circles: sensitivity and false positive rate of individual study; 
black circle: pooled sensitivity and false positive rate). Thresholds for identifying outlying studies are 0.1 for relative distance, 4.61 (upper 10 percentile of 𝛘𝟐𝟐 
distribution) for standardized residual, 0.10 for Bayesian p-value, 𝐏𝐫ሺ𝝀𝒊 ൐ 𝟏ሻ ൐ 𝟎. 𝟕𝟎 for posterior estimate of scale parameter of scale mixture of normals, and 0.015 
for influence analysis on the AUC. Outlying studies identified by each method are as follows: studies 3 and 10 for relative distance; study 1 for standardized residual; 
study 3 for Bayesian p-value; studies 1, 3, and 5 for posterior estimate of scale parameter of scale mixture of normals; studies 3 and 8 for diagnostic odds ratio; and 
studies 5, 6, and 8 for influence analysis on the AUC. 
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